IRF1 and neoplasm: This pathway has been confirmed in both genotoxic stress and radiotherapy models, where activation of ATM/ATR signaling increases PD-L1 expression via IRF1, contributing to attenuation of IFN-driven T-cell responses and promoting short-term survival of stressed tumor cells [95].